Free Trial

Amphastar Pharmaceuticals (AMPH) SEC Filings & 10K Form

Amphastar Pharmaceuticals logo
$44.61 -0.45 (-1.00%)
(As of 11/15/2024 ET)

Recent Amphastar Pharmaceuticals SEC Filings

DateFilerForm TypeView
11/13/2024
7:26 PM
Amphastar Pharmaceuticals (Issuer)
Zhou Rong (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
11/13/2024
5:55 PM
Amphastar Pharmaceuticals (Issuer)
PRINS RICHARD K (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
11/12/2024
7:05 PM
Amphastar Pharmaceuticals (Issuer)
Luo Mary Z. (Reporting)
Zhang Jack Y. (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
11/12/2024
12:29 PM
Amphastar Pharmaceuticals (Subject)
PRINS RICHARD K (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
11/12/2024
12:29 PM
Amphastar Pharmaceuticals (Subject)
Zhou Rong (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
11/08/2024
6:02 PM
Amphastar Pharmaceuticals (Issuer)
Liawatidewi Yakob (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
09/16/2024
6:09 PM
Amphastar Pharmaceuticals (Issuer)
Luo Mary Z. (Reporting)
Zhang Jack Y. (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
09/06/2024
6:48 PM
Amphastar Pharmaceuticals (Issuer)
Petersen Floyd F. (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
09/05/2024
3:48 PM
Amphastar Pharmaceuticals (Subject)
Petersen Floyd F. (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
08/30/2024
3:14 PM
Amphastar Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
08/27/2024
8:33 PM
Amphastar Pharmaceuticals (Issuer)
Zhou Rong (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
08/26/2024
4:26 PM
Amphastar Pharmaceuticals (Subject)
Zhou Rong (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
08/13/2024
4:58 PM
Amphastar Pharmaceuticals (Issuer)
PRINS RICHARD K (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
08/12/2024
4:25 PM
Amphastar Pharmaceuticals (Subject)
PRINS RICHARD K (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
08/09/2024
3:15 PM
Amphastar Pharmaceuticals (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
08/07/2024
3:22 PM
Amphastar Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
08/02/2024
3:32 PM
Amphastar Pharmaceuticals (Issuer)
PETERS WILLIAM J (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
07/31/2024
4:24 PM
Amphastar Pharmaceuticals (Subject)
PETERS WILLIAM J (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
06/28/2024
3:26 PM
Amphastar Pharmaceuticals (Issuer)
PETERS WILLIAM J (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/27/2024
3:25 PM
Amphastar Pharmaceuticals (Subject)
PETERS WILLIAM J (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
06/11/2024
5:35 PM
Amphastar Pharmaceuticals (Issuer)
Luo Mary Z. (Reporting)
Zhang Jack Y. (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/11/2024
5:32 PM
Amphastar Pharmaceuticals (Issuer)
Petersen Floyd F. (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/10/2024
3:51 PM
Amphastar Pharmaceuticals (Subject)
Petersen Floyd F. (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
06/05/2024
7:10 PM
Amphastar Pharmaceuticals (Issuer)
Lee Howard (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/05/2024
5:54 PM
Amphastar Pharmaceuticals (Issuer)
Petersen Floyd F. (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/05/2024
5:56 PM
Amphastar Pharmaceuticals (Issuer)
Deflin Gayle (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/05/2024
6:03 PM
Amphastar Pharmaceuticals (Issuer)
Gerst Diane G. (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/05/2024
4:56 PM
Amphastar Pharmaceuticals (Issuer)
ZASLOFF MICHAEL A (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/05/2024
4:58 PM
Amphastar Pharmaceuticals (Issuer)
PRINS RICHARD K (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/05/2024
5:00 PM
Amphastar Pharmaceuticals (Issuer)
Liawatidewi Yakob (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/04/2024
3:14 PM
Amphastar Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
05/21/2024
5:26 PM
Amphastar Pharmaceuticals (Issuer)
PETERS WILLIAM J (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
05/02/2024
3:56 PM
Amphastar Pharmaceuticals (Issuer)
Petersen Floyd F. (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
04/19/2024
3:21 PM
Amphastar Pharmaceuticals (Filer)
Form DEFA14A
04/12/2024
3:08 PM
Amphastar Pharmaceuticals (Filer)
Form DEF 14A
04/12/2024
3:08 PM
Amphastar Pharmaceuticals (Filer)
Form DEF 14A
04/12/2024
3:14 PM
Amphastar Pharmaceuticals (Filer)
Form DEFA14A
04/12/2024
3:14 PM
Amphastar Pharmaceuticals (Filer)
Form DEFA14A
04/02/2024
8:31 PM
Amphastar Pharmaceuticals (Issuer)
Petersen Floyd F. (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
03/19/2024
5:55 PM
Amphastar Pharmaceuticals (Issuer)
Luo Mary Z. (Reporting)
Zhang Jack Y. (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
03/08/2024
3:47 PM
Amphastar Pharmaceuticals (Issuer)
Zhou Rong (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
Buffett’s Selling Out: Is Your 401(k) About to Get Wiped Out? (Ad)

Let me share something important with you. Just a few weeks ago, Warren Buffett unloaded $932 million worth of bank stocks. He didn't do it on a whim—he knows something big is coming. The question is: Why aren't you taking action, too?

03/08/2024
3:49 PM
Amphastar Pharmaceuticals (Issuer)
Liawatidewi Yakob (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
03/08/2024
3:52 PM
Amphastar Pharmaceuticals (Issuer)
PETERS WILLIAM J (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
03/08/2024
3:32 PM
Amphastar Pharmaceuticals (Issuer)
Luo Mary Z. (Reporting)
Zhang Jack Y. (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
03/06/2024
4:54 PM
Amphastar Pharmaceuticals (Issuer)
Liawatidewi Yakob (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
03/06/2024
4:57 PM
Amphastar Pharmaceuticals (Issuer)
ZASLOFF MICHAEL A (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
03/06/2024
5:29 PM
Amphastar Pharmaceuticals (Issuer)
Luo Mary Z. (Reporting)
Zhang Jack Y. (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
03/06/2024
4:49 PM
Amphastar Pharmaceuticals (Issuer)
PETERS WILLIAM J (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
03/06/2024
4:51 PM
Amphastar Pharmaceuticals (Issuer)
Zhou Rong (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
03/06/2024
9:23 AM
Amphastar Pharmaceuticals (Subject)
FEDERATED HERMES, INC. (Filed by)
FEDERATED HERMES, INC. (Filed by)
Form SC 13G/A
03/05/2024
12:21 PM
Amphastar Pharmaceuticals (Subject)
ZASLOFF MICHAEL A (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
03/04/2024
7:35 PM
Amphastar Pharmaceuticals (Issuer)
Petersen Floyd F. (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
02/29/2024
3:53 PM
Amphastar Pharmaceuticals (Filer)
Form S-8
Registration statement under Securities Act of 1933 to be offered to employees pursuant to certain plans  
02/28/2024
3:38 PM
Amphastar Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
02/09/2024
4:21 PM
Amphastar Pharmaceuticals (Subject)
Zhang Jack Y. (Filed by)
Form SC 13G/A
02/02/2024
6:37 PM
Amphastar Pharmaceuticals (Issuer)
Petersen Floyd F. (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
01/23/2024
10:53 AM
Amphastar Pharmaceuticals (Subject)
BlackRock Inc. (Filed by)
Form SC 13G/A
01/17/2024
1:36 PM
Amphastar Pharmaceuticals (Subject)
FEDERATED HERMES, INC. (Filed by)
FEDERATED HERMES, INC. (Filed by)
Form SC 13G/A
01/11/2024
3:37 PM
Amphastar Pharmaceuticals (Issuer)
Luo Mary Z. (Reporting)
Zhang Jack Y. (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
01/10/2024
5:27 PM
Amphastar Pharmaceuticals (Issuer)
Luo Mary Z. (Reporting)
Zhang Jack Y. (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
01/10/2024
3:25 PM
Amphastar Pharmaceuticals (Subject)
Luo Mary Z. (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
01/09/2024
3:22 PM
Amphastar Pharmaceuticals (Subject)
Luo Mary Z. (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
01/08/2024
3:23 PM
Amphastar Pharmaceuticals (Subject)
Luo Mary Z. (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
01/03/2024
6:25 PM
Amphastar Pharmaceuticals (Issuer)
Petersen Floyd F. (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
12/05/2023
5:25 PM
Amphastar Pharmaceuticals (Issuer)
Zhou Rong (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
12/04/2023
7:49 PM
Amphastar Pharmaceuticals (Issuer)
Petersen Floyd F. (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
12/01/2023
3:11 PM
Amphastar Pharmaceuticals (Subject)
Petersen Floyd F. (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
11/20/2023
4:23 PM
Amphastar Pharmaceuticals (Issuer)
PRINS RICHARD K (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
11/17/2023
11:34 AM
Amphastar Pharmaceuticals (Subject)
Zhou Rong (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
(Data available from 1/1/2016 forward)


Related Companies and Tools


This page (NASDAQ:AMPH) was last updated on 11/17/2024 by MarketBeat.com Staff
From Our Partners